` DRMA (Dermata Therapeutics Inc) vs JNJ (Johnson & Johnson) Comparison - Alpha Spread

DRMA
vs
JNJ

Over the past 12 months, DRMA has underperformed JNJ, delivering a return of -81% compared to the JNJ's +49% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
DRMA
JNJ
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

DRMA Intrinsic Value
LOCKED
Unlock
JNJ Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Dermata Therapeutics Inc
NASDAQ:DRMA
1.35 USD
Johnson & Johnson
NYSE:JNJ
234.54 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
DRMA, JNJ

DRMA
JNJ
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Dermata Therapeutics Inc
Revenue
Johnson & Johnson
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
DRMA, JNJ

DRMA
JNJ
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Dermata Therapeutics Inc
NASDAQ:DRMA
Johnson & Johnson
NYSE:JNJ
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

DRMA
0%
JNJ
67.9%

Operating Margin

DRMA
0%
JNJ
27.9%

Net Margin

DRMA
0%
JNJ
21.8%

FCF Margin

DRMA
0%
JNJ
20.4%

ROE

DRMA
-194.2%
JNJ
27.5%

ROA

DRMA
-132.6%
JNJ
11.1%

ROIC

DRMA
2 802.8%
JNJ
14.5%

ROCE

DRMA
-199.7%
JNJ
19.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
DRMA, JNJ

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
DRMA, JNJ

Performance Gap Between DRMA and JNJ
LOCKED
Unlock

Performance By Year
DRMA, JNJ

Loading
DRMA
JNJ
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare DRMA to other stocks
LLY
Eli Lilly and Co
More expensive
vs DRMA
ROG
Roche Holding AG
More expensive
vs DRMA
AZN
AstraZeneca PLC
More expensive
vs DRMA
NOVN
Novartis AG
More expensive
vs DRMA
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett